Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL IMMUNE CHECKPOINT INHIBITORS INDUSTRY
2.1 Summary about Immune Checkpoint Inhibitors Industry
2.2 Immune Checkpoint Inhibitors Market Trends
2.2.1 Immune Checkpoint Inhibitors Production & Consumption Trends
2.2.2 Immune Checkpoint Inhibitors Demand Structure Trends
2.3 Immune Checkpoint Inhibitors Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 PD-1/PD-L1
4.2.2 CTLA-4
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Lung Cancer
4.3.2 Colorectal Cancer
4.3.3 Breast Cancer
4.3.4 Prostate Cancer
4.3.5 Melanoma
4.3.6 Blood Cancer
4.3.7 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 PD-1/PD-L1
5.2.2 CTLA-4
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Lung Cancer
5.3.2 Colorectal Cancer
5.3.3 Breast Cancer
5.3.4 Prostate Cancer
5.3.5 Melanoma
5.3.6 Blood Cancer
5.3.7 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 PD-1/PD-L1
6.2.2 CTLA-4
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Lung Cancer
6.3.2 Colorectal Cancer
6.3.3 Breast Cancer
6.3.4 Prostate Cancer
6.3.5 Melanoma
6.3.6 Blood Cancer
6.3.7 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 PD-1/PD-L1
7.2.2 CTLA-4
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Lung Cancer
7.3.2 Colorectal Cancer
7.3.3 Breast Cancer
7.3.4 Prostate Cancer
7.3.5 Melanoma
7.3.6 Blood Cancer
7.3.7 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 PD-1/PD-L1
8.2.2 CTLA-4
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Lung Cancer
8.3.2 Colorectal Cancer
8.3.3 Breast Cancer
8.3.4 Prostate Cancer
8.3.5 Melanoma
8.3.6 Blood Cancer
8.3.7 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 PD-1/PD-L1
9.2.2 CTLA-4
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Lung Cancer
9.3.2 Colorectal Cancer
9.3.3 Breast Cancer
9.3.4 Prostate Cancer
9.3.5 Melanoma
9.3.6 Blood Cancer
9.3.7 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Bristol Myer Squibb
10.1.2 AstraZeneca
10.1.3 Merck & Co.
10.1.4 Roche / Genentech
10.1.5 Incyte Corporation
10.1.6 NewLink Genetics
10.1.7 ArGEN-X
10.1.8 Seattle Genetics
10.1.9 Pfizer
10.1.10 MacroGenics
10.1.11 Celldex Therapeutics
10.1.12 CureTech
10.1.13 Immutep
10.1.14 Innate Pharma
10.1.15 Sorrento Therapeutics
10.1.16 GlaxoSmithKline
10.1.17 GITR, Inc
10.2 Immune Checkpoint Inhibitors Sales Date of Major Players (2017-2020e)
10.2.1 Bristol Myer Squibb
10.2.2 AstraZeneca
10.2.3 Merck & Co.
10.2.4 Roche / Genentech
10.2.5 Incyte Corporation
10.2.6 NewLink Genetics
10.2.7 ArGEN-X
10.2.8 Seattle Genetics
10.2.9 Pfizer
10.2.10 MacroGenics
10.2.11 Celldex Therapeutics
10.2.12 CureTech
10.2.13 Immutep
10.2.14 Innate Pharma
10.2.15 Sorrento Therapeutics
10.2.16 GlaxoSmithKline
10.2.17 GITR, Inc
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
Table Immune Checkpoint Inhibitors Product Type Overview
Table Immune Checkpoint Inhibitors Product Type Market Share List
Table Immune Checkpoint Inhibitors Product Type of Major Players
Table Brief Introduction of Bristol Myer Squibb
Table Brief Introduction of AstraZeneca
Table Brief Introduction of Merck & Co.
Table Brief Introduction of Roche / Genentech
Table Brief Introduction of Incyte Corporation
Table Brief Introduction of NewLink Genetics
Table Brief Introduction of ArGEN-X
Table Brief Introduction of Seattle Genetics
Table Brief Introduction of Pfizer
Table Brief Introduction of MacroGenics
Table Brief Introduction of Celldex Therapeutics
Table Brief Introduction of CureTech
Table Brief Introduction of Immutep
Table Brief Introduction of Innate Pharma
Table Brief Introduction of Sorrento Therapeutics
Table Brief Introduction of GlaxoSmithKline
Table Brief Introduction of GITR, Inc
Table Products & Services of Bristol Myer Squibb
Table Products & Services of AstraZeneca
Table Products & Services of Merck & Co.
Table Products & Services of Roche / Genentech
Table Products & Services of Incyte Corporation
Table Products & Services of NewLink Genetics
Table Products & Services of ArGEN-X
Table Products & Services of Seattle Genetics
Table Products & Services of Pfizer
Table Products & Services of MacroGenics
Table Products & Services of Celldex Therapeutics
Table Products & Services of CureTech
Table Products & Services of Immutep
Table Products & Services of Innate Pharma
Table Products & Services of Sorrento Therapeutics
Table Products & Services of GlaxoSmithKline
Table Products & Services of GITR, Inc
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Immune Checkpoint Inhibitors Market Forecast (Million USD) by Region 2021f-2026f
Table Global Immune Checkpoint Inhibitors Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Immune Checkpoint Inhibitors Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Immune Checkpoint Inhibitors Market Forecast (Million USD) Share by Demand 2021f-2026f